Access to treatment
Access to treatment 18/05/2012
Malaysians seek license for Abbott AIDS drug
Abbott Laboratories is facing a battle over its Kaletra HIV medication in yet another country.
Access to treatment 17/05/2012
New trade deal would benefit big pharma at AIDS programs' expense
U.S. negotiators are seeking to impose a set of restrictive intellectual property laws that would help American drug companies secure long-term monopolies overseas.
Access to treatment 14/05/2012
UNITAID: Five years of health innovation brings new approach and new medicines to developing country markets
Through spearheading innovative initiatives and providing financing for global health over the past five years, UNITAID has had a dramatic impact on millions of lives, using creative market approaches to increase access to treatment and diagnostics for HIV, malaria and tuberculosis.
Access to treatment 11/05/2012
New report offers a blueprint to boost research and development (R&D) for diseases of the developing world
A new study is released reviewing initiatives to encourage research and development (R&D) for diseases such as HIV, tuberculosis, malaria and neglected tropical diseases.
Access to treatment 09/05/2012
A patent way to get cheaper drugs for poor nations
Amid a growing crisis in financing treatments for AIDS, tuberculosis and malaria in the developing world, an arm of the World Health Organization will meet in Geneva later this month to consider alternative ways of producing lower-cost drugs, vaccines and diagnostic tools to fight the those diseases in poor countries.
Access to treatment 09/05/2012
AllAfrica.com interviews international president of MSF
Gains made in reducing medicine costs and providing treatment for AIDS, tuberculosis and malaria discussed as well as the challenges MSF faces in remaining independent and principled in conflict situations.
Access to treatment 09/05/2012
Bayer challenges compulsory license in India
Patient advocacy groups and non-governmental organizations called the decision to issue the license a game changer.
Access to treatment 09/05/2012
Bernie Sanders advocates a free market in AIDS drugs
There are more efficient mechanisms than patent monopolies to finance drug research.
Access to treatment 08/05/2012
German ministry advises developing countries not to sign ACTA
Negative effects on generic drug distribution and trade is a huge concern.
Access to treatment 04/05/2012
Abbott, Kaletra pricing and AIDS in Colombia
In the latest struggle between Abbott Laboratories and patient advocacy groups, an administrative judge in Colombia recently ruled that the drugmaker and the government health ministry improperly maintained the price of the Kaletra AIDS medication above the so-called reference price.
Access to treatment 28/04/2012
Will India continue to supply cheap drugs?
Millions will die if India cannot produce the new HIV/AIDS medicines in the future –it is a matter of life and death.
Access to treatment 27/04/2012
Experts at WHO say patent pools can stimulate research, medicines access
Patent pools are one of the proposals likely to be effective in stimulating new research and development of medicines needed in developing countries.
Access to treatment 25/04/2012
Book offers timely insights on IP, drugs and public health in developing countries
A recent book comes in time for the international policy debates coming to a head over access to medicines, intellectual property rights and public health in developing countries.
Access to treatment 24/04/2012
Text of Kenya judgment on anti-counterfeiting now available
Kenya’s first victory on the right to health.
Access to treatment 21/04/2012
UNAIDS welcomes Kenya High Court judgment on anti-counterfeit law
UNAIDS commends the High Court of Kenya for a ruling that will safeguard access to affordable and quality life-saving generic medicines.
Access to treatment 18/04/2012
Frontline: Drug and duplicity
Novartis's overzealous defence of intellectual property rights knows no bounds. It seeks to strengthen and lengthen patent monopolies and prevent the use of hard-fought flexibilities that ensure that poor people will not be left to die.
Access to treatment 18/04/2012
US court backs Sun over Novo in key patent case
Generic drugmakers, especially Sun Pharmaceutical Industries, are celebrating a landmark ruling by the US Supreme Court which has ruled in favour of the Indian drugmaker in its long-running patent battle with Novo Nordisk over the latter's diabetes drug Prandin.
Access to treatment 17/04/2012
Results for Development: Final report on Patent Pools
The Medicines Patent Pool could speed up development of fixed-dose combination pills, paediatric medicines and heat stable formulations needed in resource-poor settings, as well as help stimulate generic manufacture of lower cost medicines.
Access to treatment 16/04/2012
UNITAID: Open call for letters of intent
UNITAID is pleased to announce an open call for Letters of Intent on the topic of improving access to key preventive, diagnostic and treatment commodities for HIV, TB and malaria through market-based approaches.
Access to treatment 16/04/2012
Message from Charles Clift, Chair, Medicines Patent Pool
Ellen ‘t Hoen has informed the Board she will step down as Executive Director of the Medicines Patent Pool on 1 May.
More...
